Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

"When you have two-thirds plus of the active duty military force that's obese ... you know you've got a huge problem," ...

Statistics from 2023 on U.S. obesity rates reveal that in every U.S. state, one in every five people now has obesity, ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...

WASHINGTON — The rate of obesity among US adults was 35% or higher in 23 states in 2023, having increased over several ...

Novo Nordisk’s obesity drug Wegovy is now recommended by EU regulatory authorities for obesity-related heart conditions.

The medtech industry hopes to capitalise on increased awareness about the obesity space to promote multidisciplinary ...

Australian researchers said that supervised diets with intermittent fasting were for children with serious health conditions, ...

BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking ...

Air pollution, high temperatures, and risk factors such as obesity and high blood pressure are driving global increases in ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

(HealthDay News) — Statistics from 2023 on US obesity rates reveal that in every US state, one in every five people now has obesity, according to data released Thursday by the US Centers for Disease ...